Sunzen Biotech Berhad reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was MYR 90.44 million compared to MYR 82.23 million a year ago. Net income was MYR 0.698 million compared to net loss of MYR 13.23 million a year ago.

Basic earnings per share from continuing operations was MYR 0.0012 compared to basic loss per share from continuing operations of MYR 0.025 a year ago. Diluted earnings per share from continuing operations was MYR 0.0011 compared to diluted loss per share from continuing operations of MYR 0.025 a year ago.